News

SIU School of Medicine economic impact adds $1 billion to Illinois

A new report highlights SIU School of Medicine's fiscal impact as one of the top employers in central and southern Illinois.
News

SIU School of Medicine economic impact adds $1 billion to Illinois

A new report highlights SIU School of Medicine's fiscal impact as one of the top employers in central and southern Illinois.
News

SIU School of Medicine economic impact adds $1 billion to Illinois

A new report highlights SIU School of Medicine's fiscal impact as one of the top employers in central and southern Illinois.
News

SIU School of Medicine economic impact adds $1 billion to Illinois

A new report highlights SIU School of Medicine's fiscal impact as one of the top employers in central and southern Illinois.
News

UIS researchers partner with SIU School of Medicine to study how cancer spreads

Scientists at the University of Illinois Springfield and SIU School of Medicine are teaming up to investigate how certain cells in the body connect and encourage the spread of cancer.
News

UIS researchers partner with SIU School of Medicine to study how cancer spreads

Scientists at the University of Illinois Springfield and SIU School of Medicine are teaming up to investigate how certain cells in the body connect and encourage the spread of cancer.
Trial
Neurology

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)

Active recruiting

The purpose of this study is to assess the effect of BMS-986446 vs placebo on delay of cognitive memory and functional decline in participants (age 50-80) with early Alzheimer's Disease.

News

Senolytic treatment improves cognition in female Alzheimer’s mice

Research shows differing effects from treatment for male, female models One of the many confounding questions about Alzheimer’s disease is why women are at greater risk. Of the approximately 7 million people diagnosed with Alzheimer’s in the United States, nearly two-thirds are women. There are several theories as to why, including that women live longer than men, societal factors, biological factors and more. But the question is far from answered. That gender imbalance may be a significant factor when developing new treatments as well. A recent study from the Hascup Lab at the Smith Alzheimer
News

Jensik honored as SIU Inventor of the Year

Phil Jensik, PhD, associate professor in SIU School of Medicine’s Department of Physiology, has been named SIU’s Inventor of the Year for 2024. His research explores mutations in genes that result in neurodevelopmental disorders such as intellectual disabilities, speech disorders and autism, affecting about 1 in 10 U.S. children.
News

Jensik honored as SIU Inventor of the Year

Phil Jensik, PhD, associate professor in SIU School of Medicine’s Department of Physiology, has been named SIU’s Inventor of the Year for 2024. His research explores mutations in genes that result in neurodevelopmental disorders such as intellectual disabilities, speech disorders and autism, affecting about 1 in 10 U.S. children.
Subscribe to Research